New York Life Trust’s Colgate-Palmolive CL Stock Holding History

New York Life Trust’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-96	Closed	-$6K	–	200
2016 Q4	$6K	Buy	+96	New	+$6.58K	0.03%	197

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

New York Life Trust's CL Position: Q1 2017 in Review

New York Life Trust sold out of Colgate-Palmolive (CL) in Q1 2017, closing a stake of 96 shares — an estimated $6K sold.

New York Life Trust first reported a position in CL in Q4 2016 and held it in 1 quarter. The position peaked at $6K in Q4 2016. 1,365 funds tracked by Wall St. Rank hold CL as of Q1 2017.

New York Life Trust reported no remaining Colgate-Palmolive position as of Q1 2017 after selling out during the quarter.
New York Life Trust sold 96 Colgate-Palmolive shares in Q1 2017, an estimated $6K.
New York Life Trust first reported a position in Colgate-Palmolive in Q4 2016 and held it in 1 quarter.
New York Life Trust's Colgate-Palmolive position peaked at $6K in Q4 2016.
1,365 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.